Publication of Annual Report

RNS Number : 1323I

Medica Group PLC

12 April 2022

 

12 April 2022

Medica Group Plc

Publication of Annual Report

Medica Group Plc (LSE:MGP, the "Company"), the UK market leader by revenue in the provision of teleradiology services, today announces that the Company's annual report and accounts (Annual Report) for the year ended 31 December 2021, is now available on the Company's website at:

www.medicagroupplc.com/investors/results-and-reports .

Th Annual Report will be posted to those shareholders who have opted out of electronic communications shortly.

A copy of the Annual Report will also be submitted to the National Storage Mechanism and will be available for inspection in due course at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism  

Notice of the Company's 2022 Annual General Meeting (AGM) will be posted to shareholders and available on the Company's website in May, and accordingly the Company will publish a further announcement at that time. The AGM will be held on 27 June 2022 at 11.00am at the offices of DLA Piper at 160 Aldersgate Street, London, EC1A 4HT.

For further information, please contact:  

Medica Group Plc: Stuart Quin, Chief Executive Officer Richard Jones, Chief Financial Officer	[phone]
FTI Consulting Victoria Foster Mitchell Sam Purewal	[phone]
Liberum (Joint Broker) Phil Walker Richard Lindley	[phone]
Numis (Joint Broker) Freddie Barnfield Duncan Monteith Euan Brown	[phone]

About Medica Group PLC

Medica is the market leader in the UK and Ireland for the provision of teleradiology services, providing outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerised tomography), ultrasound and plain film (x-ray) images. Medica also offers diabetic retinopathy screening in Ireland.

Medica contracts with the largest pool of consultant radiologists in the UK and Ireland, performing remote access teleradiology across its customer base of more than 100 NHS Trusts in the UK, the Irish HSE, private hospital and insurance groups, as well as diagnostic imaging companies. This enables the Company to offer a fast, responsive service. In addition,  Medica operates in Australia and New Zealand through MedX, a 50:50 Joint Venture with Integral Diagnostics Limited Pty.

The Company currently offers two primary services to hospital radiology departments:

· NightHawk - urgent reporting service

· Elective - includes routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.

These services are underpinned by Medica's bespoke, secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and consultant radiologists who contract with the Company. Direct RIS access ensures that where the wider patient medical history is available, it can be reviewed by the consultant as part of every report.

Through its subsidiary, RadMD, in the United States, Medica also provides pharmaceutical and biotech clients and contract research organisations (CROs) with high quality, complex imaging services for international clinical trials. RadMD has gained vast experience in the space, having contributed to over 500 international clinical trials, in all phases of clinical research from proof of concept to phase III and with expertise in oncology, as well as a wider range of therapeutic areas including medical devices, neurology and cardiovascular.

For more information please visit:  www.medicagroupplc.com  

 

END

 

 

ACSBLLFFLZLLBBZ